Inmedix Inc
Signal active
Organization
Contact Information
Overview
Inmedix has discovered and is commercializing a novel class of diagnostics and therapeutics. Their approach focuses on autonomic nervous system (ANS) control of stress responses within the brain. In the setting of an autoimmune disease, ANS stress can significantly intensify an autoimmune disease. They call it Immuno-autonomics. They seek to understand and block this process to allow current autoimmune disease therapies to work much better.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2017
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Inmedix Inc headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $669.6M in funding across 72 round(s). With a team of 1-10 employees, Inmedix Inc is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Inmedix Inc, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
6
Investors
1
Lead Investors
0
Total Funding Amount
$9.3M
Details
5
Inmedix Inc has raised a total of $9.3M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 2.0M | ||
| 2022 | Seed | 3.0M | ||
| 2022 | Seed | |||
| 2020 | Seed |
Investors
Inmedix Inc is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Inmedix Inc | - | FUNDING ROUND - Inmedix Inc | 2.0M |
| Keiretsu Capital | - | FUNDING ROUND - Keiretsu Capital | 2.0M |
| Inmedix Inc | - | FUNDING ROUND - Inmedix Inc | undefined |
| Keiretsu Capital | - | FUNDING ROUND - Keiretsu Capital | undefined |
Recent Activity
There is no recent news or activity for this profile.